Skip to content
Prostate Cancer Research Center

Faculty of Medicine and Health Technology

Epidemiology

2020

  1. Abuhamed, J, Nikkilä, A, Lohi, O, Auvinen, A. Trends of computed tomography use among children in Finland. Eur J Radiol Open. 2020;7 :100290. doi: 10.1016/j.ejro.2020.100290. PubMed PMID:33335951 PubMed Central PMC7733003.
  2. Jen, HH, Chang, WJ, Hsu, CY, Yen, AM, Auvinen, A, Chen, TH et al.. Sojourn-time-corrected receiver operating characteristic curve (ROC) for prostate specific antigen (PSA) test in population-based prostate cancer screening. Sci Rep. 2020;10 (1):20665. doi: 10.1038/s41598-020-77668-w. PubMed PMID:33244038 PubMed Central PMC7691355.
  3. Sipeky, C, Talala, KM, Tammela, TLJ, Taari, K, Auvinen, A, Schleutker, J et al.. Prostate cancer risk prediction using a polygenic risk score. Sci Rep. 2020;10 (1):17075. doi: 10.1038/s41598-020-74172-z. PubMed PMID:33051487 PubMed Central PMC7553910.
  4. Pakarainen, T, Nevalainen, J, Talala, K, Taari, K, Raitanen, J, Kujala, P et al.. Number of screening rounds attended and incidence of high-risk prostate cancer in the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC). Cancer. 2021;127 (2):188-192. doi: 10.1002/cncr.33254. PubMed PMID:33048394 .
  5. Hietikko, R, Kilpeläinen, TP, Kenttämies, A, Ronkainen, J, Ijäs, K, Lind, K et al.. Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study. Cancer Imaging. 2020;20 (1):72. doi: 10.1186/s40644-020-00351-w. PubMed PMID:33036660 PubMed Central PMC7547469.
  6. Pöyhönen, A, Åkerla, J, Koskimäki, J, Tammela, TLJ, Auvinen, A. Seasonal changes in occurrence and severity of lower urinary tract symptoms-Tampere Aging Male Urologic Study (TAMUS). Low Urin Tract Symptoms. 2021;13 (2):216-223. doi: 10.1111/luts.12353. PubMed PMID:33034153 .
  7. Niskanen, L, Partonen, T, Auvinen, A, Haukka, J. Trends and predictors in all-cause and cause-specific mortality in diabetic and reference populations during 21 years of follow-up. J Epidemiol Community Health. 2020;74 (11):950-956. doi: 10.1136/jech-2019-213602. PubMed PMID:32620580 .
  8. Siltari, A, Murtola, TJ, Talala, K, Taari, K, Tammela, TLJ, Auvinen, A et al.. Antihypertensive drug use and prostate cancer-specific mortality in Finnish men. PLoS One. 2020;15 (6):e0234269. doi: 10.1371/journal.pone.0234269. PubMed PMID:32598349 PubMed Central PMC7323967.
  9. Omar, MI, Roobol, MJ, Ribal, MJ, Abbott, T, Agapow, PM, Araujo, S et al.. Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer research. Nat Rev Urol. 2020;17 (8):482. doi: 10.1038/s41585-020-0355-3. PubMed PMID:32587405 .
  10. Tomer, A, Nieboer, D, Roobol, MJ, Bjartell, A, Steyerberg, EW, Rizopoulos, D et al.. Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance. BJU Int. 2021;127 (1):96-107. doi: 10.1111/bju.15136. PubMed PMID:32531869 PubMed Central PMC7818468.
  11. Talala, K, Heinävaara, S, Taari, K, Tammela, TLJ, Kujala, P, Stenman, UH et al.. Long-term health-related quality of life among men with prostate cancer in the Finnish randomized study of screening for prostate cancer. Cancer Med. 2020;9 (15):5643-5654. doi: 10.1002/cam4.3181. PubMed PMID:32500650 PubMed Central PMC7402814.
  12. Omar, MI, Roobol, MJ, Ribal, MJ, Abbott, T, Agapow, PM, Araujo, S et al.. Introducing PIONEER: a project to harness big data in prostate cancer research. Nat Rev Urol. 2020;17 (6):351-362. doi: 10.1038/s41585-020-0324-x. PubMed PMID:32461687 .
  13. Tettamanti, G, Auvinen, A, Åkerstedt, T, Kojo, K, Ahlbom, A, Heinävaara, S et al.. Long-term effect of mobile phone use on sleep quality: Results from the cohort study of mobile phone use and health (COSMOS). Environ Int. 2020;140 :105687. doi: 10.1016/j.envint.2020.105687. PubMed PMID:32276731 PubMed Central PMC7272128.
  14. Kilpeläinen, TP, Talala, K, Taari, K, Raitanen, J, Kujala, P, Pylväläinen, J et al.. Patients’ education level and treatment modality for prostate cancer in the Finnish Randomized Study of Screening for Prostate Cancer. Eur J Cancer. 2020;130 :204-210. doi: 10.1016/j.ejca.2020.02.045. PubMed PMID:32229417 .
  15. Karalexi, MA, Dessypris, N, Ma, X, Spector, LG, Marcotte, E, Clavel, J et al.. Age-, sex- and disease subtype-related foetal growth differentials in childhood acute myeloid leukaemia risk: A Childhood Leukemia International Consortium analysis. Eur J Cancer. 2020;130 :1-11. doi: 10.1016/j.ejca.2020.01.018. PubMed PMID:32163883 .
  16. Nikkilä, A, Raitanen, J, Lohi, O, Auvinen, A. Radiation exposure from computerized tomography and risk of childhood leukemia: Finnish register-based case-control study of childhood leukemia (FRECCLE). Haematologica. 2020;105 (3):849-850. doi: 10.3324/haematol.2019.245704. PubMed PMID:32115415 PubMed Central PMC7049358.
  17. Nikkilä, A, Arvela, H, Mehtonen, J, Raitanen, J, Heinäniemi, M, Lohi, O et al.. Predicting residential radon concentrations in Finland: Model development, validation, and application to childhood leukemia. Scand J Work Environ Health. 2020;46 (3):278-292. doi: 10.5271/sjweh.3867. PubMed PMID:31763683 .
  18. Mazzei-Abba, A, Folly, CL, Coste, A, Wakeford, R, Little, MP, Raaschou-Nielsen, O et al.. Epidemiological studies of natural sources of radiation and childhood cancer: current challenges and future perspectives. J Radiol Prot. 2020;40 (1):R1-R23. doi: 10.1088/1361-6498/ab5a38. PubMed PMID:31751953 PubMed Central PMC10654695.
  19. Kalapara, AA, Verbeek, JFM, Nieboer, D, Fahey, M, Gnanapragasam, V, Van Hemelrijck, M et al.. Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance Initiative. Eur Urol Oncol. 2020;3 (1):80-91. doi: 10.1016/j.euo.2019.08.014. PubMed PMID:31564531 .
  20. Seibold, P, Auvinen, A, Averbeck, D, Bourguignon, M, Hartikainen, JM, Hoeschen, C et al.. Clinical and epidemiological observations on individual radiation sensitivity and susceptibility. Int J Radiat Biol. 2020;96 (3):324-339. doi: 10.1080/09553002.2019.1665209. PubMed PMID:31539290 .
  21. Pesonen, JS, Cartwright, R, Vernooij, RWM, Aoki, Y, Agarwal, A, Mangera, A et al.. The Impact of Nocturia on Mortality: A Systematic Review and Meta-Analysis. J Urol. 2020;203 (3):486-495. doi: 10.1097/JU.0000000000000463. PubMed PMID:31364920 .

Search PubMed

2019

Search PubMed

2018

Search PubMed

2017

Search PubMed

2016

Search PubMed

2015

  1. Nevalainen, O, Simola, M, Ansakorpi, H, Raitanen, J, Artama, M, Isojärvi, J et al.. Epilepsy, excess deaths and years of life lost from external causes. Eur J Epidemiol. 2016;31 (5):445-53. doi: 10.1007/s10654-015-0095-5. PubMed PMID:26520637 .
  2. Rahu, K, Rahu, M, Tekkel, M, Veidebaum, T, Hakulinen, T, Auvinen, A et al.. Chernobyl cleanup workers from Estonia: cohort description and related epidemiological research. J Radiol Prot. 2015;35 (4):R35-45. doi: 10.1088/0952-4746/35/4/R35. PubMed PMID:26512763 .
  3. Auvinen, A. [How do I write a scientific article–advice to a young researcher]. Duodecim. 2015;131 (16):1460-6. . PubMed PMID:26485939 .
  4. Friis, S, Kesminiene, A, Espina, C, Auvinen, A, Straif, K, Schüz, J et al.. European Code against Cancer 4th Edition: Medical exposures, including hormone therapy, and cancer. Cancer Epidemiol. 2015;39 Suppl 1 :S107-19. doi: 10.1016/j.canep.2015.08.003. PubMed PMID:26390952 .
  5. Davies, NM, Gaunt, TR, Lewis, SJ, Holly, J, Donovan, JL, Hamdy, FC et al.. The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium. Cancer Causes Control. 2015;26 (11):1603-16. doi: 10.1007/s10552-015-0654-9. PubMed PMID:26387087 PubMed Central PMC4596899.
  6. Pashayan, N, Pharoah, PD, Schleutker, J, Talala, K, Tammela, TLj, Määttänen, L et al.. Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC. Br J Cancer. 2015;113 (7):1086-93. doi: 10.1038/bjc.2015.289. PubMed PMID:26291059 PubMed Central PMC4651137.
  7. Auvinen, A, Moss, SM, Tammela, TL, Taari, K, Roobol, MJ, Schröder, FH et al.. Absolute Effect of Prostate Cancer Screening: Balance of Benefits and Harms by Center within the European Randomized Study of Prostate Cancer Screening. Clin Cancer Res. 2016;22 (1):243-9. doi: 10.1158/1078-0432.CCR-15-0941. PubMed PMID:26289069 PubMed Central PMC4951205.
  8. Ryödi, E, Metso, S, Jaatinen, P, Huhtala, H, Saaristo, R, Välimäki, M et al.. Cancer Incidence and Mortality in Patients Treated Either With RAI or Thyroidectomy for Hyperthyroidism. J Clin Endocrinol Metab. 2015;100 (10):3710-7. doi: 10.1210/jc.2015-1874. PubMed PMID:26262435 .
  9. Eloranta, K, Auvinen, A. Population attitudes towards research use of health care registries: a population-based survey in Finland. BMC Med Ethics. 2015;16 :48. doi: 10.1186/s12910-015-0040-x. PubMed PMID:26183438 PubMed Central PMC4504396.
  10. Szulkin, R, Whitington, T, Eklund, M, Aly, M, Eeles, RA, Easton, D et al.. Prediction of individual genetic risk to prostate cancer using a polygenic score. Prostate. 2015;75 (13):1467-74. doi: 10.1002/pros.23037. PubMed PMID:26177737 PubMed Central PMC7745998.
  11. Schüz, J, Espina, C, Villain, P, Herrero, R, Leon, ME, Minozzi, S et al.. European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk. Cancer Epidemiol. 2015;39 Suppl 1 :S1-10. doi: 10.1016/j.canep.2015.05.009. PubMed PMID:26164654 .
  12. McColl, N, Auvinen, A, Kesminiene, A, Espina, C, Erdmann, F, de Vries, E et al.. European Code against Cancer 4th Edition: Ionising and non-ionising radiation and cancer. Cancer Epidemiol. 2015;39 Suppl 1 :S93-100. doi: 10.1016/j.canep.2015.03.016. PubMed PMID:26126928 .
  13. Nevalainen, OP, Ansakorpi, H, Auvinen, A. Epilepsy-related clinical characteristics and mortality: a systematic review and meta-analysis. Neurology. 2015;84 (17):1823-4. . PubMed PMID:26106661 .
  14. Greinert, R, de Vries, E, Erdmann, F, Espina, C, Auvinen, A, Kesminiene, A et al.. European Code against Cancer 4th Edition: Ultraviolet radiation and cancer. Cancer Epidemiol. 2015;39 Suppl 1 :S75-83. doi: 10.1016/j.canep.2014.12.014. PubMed PMID:26096748 .
  15. Veitonmäki, T, Murtola, TJ, Määttänen, L, Taari, K, Stenman, UH, Tammela, TL et al.. Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial. Prostate. 2015;75 (13):1394-402. doi: 10.1002/pros.23020. PubMed PMID:26073992 .
  16. Kreuzer, M, Auvinen, A, Cardis, E, Hall, J, Jourdain, JR, Laurier, D et al.. Low-dose ionising radiation and cardiovascular diseases–Strategies for molecular epidemiological studies in Europe. Mutat Res Rev Mutat Res. 2015;764 :90-100. doi: 10.1016/j.mrrev.2015.03.002. PubMed PMID:26041268 .
  17. Amin Al Olama, A, Dadaev, T, Hazelett, DJ, Li, Q, Leongamornlert, D, Saunders, EJ et al.. Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans. Hum Mol Genet. 2015;24 (19):5589-602. doi: 10.1093/hmg/ddv203. PubMed PMID:26025378 PubMed Central PMC4572072.
  18. Shrestha, M, Raitanen, J, Salminen, T, Lahkola, A, Auvinen, A. Pituitary tumor risk in relation to mobile phone use: A case-control study. Acta Oncol. 2015;54 (8):1159-65. doi: 10.3109/0284186X.2015.1045624. PubMed PMID:25982941 .
  19. Schröder, F, Hugosson, J, Carlsson, S, Moss, S, Roobol, M, Auvinen, A et al.. Prostate cancer screening in Europe – Authors’ reply. Lancet. 2015;385 (9977):1507-8. doi: 10.1016/S0140-6736(15)60749-8. PubMed PMID:25933276 .
  20. Auvinen, A, Kivelä, T, Heinävaara, S, Mrena, S. Eye Lens Opacities Among Physicians Occupationally Exposed to Ionizing Radiation. Ann Occup Hyg. 2015;59 (7):945-8. doi: 10.1093/annhyg/mev022. PubMed PMID:25868644 .
  21. Amin Al Olama, A, Benlloch, S, Antoniou, AC, Giles, GG, Severi, G, Neal, DE et al.. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci. Cancer Epidemiol Biomarkers Prev. 2015;24 (7):1121-9. doi: 10.1158/1055-9965.EPI-14-0317. PubMed PMID:25837820 PubMed Central PMC4491026.
  22. Murtola, TJ, Wahlfors, T, Haring, A, Taari, K, Stenman, UH, Tammela, TL et al.. Polymorphisms of Genes Involved in Glucose and Energy Metabolic Pathways and Prostate Cancer: Interplay with Metformin. Eur Urol. 2015;68 (6):1089-97. doi: 10.1016/j.eururo.2015.03.026. PubMed PMID:25819720 .
  23. Buzzoni, C, Auvinen, A, Roobol, MJ, Carlsson, S, Moss, SM, Puliti, D et al.. Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer. Eur Urol. 2015;68 (5):885-90. doi: 10.1016/j.eururo.2015.02.042. PubMed PMID:25791513 PubMed Central PMC4982869.
  24. Stegeman, S, Amankwah, E, Klein, K, O’Mara, TA, Kim, D, Lin, HY et al.. A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer. Cancer Discov. 2015;5 (4):368-79. doi: 10.1158/2159-8290.CD-14-1057. PubMed PMID:25691096 PubMed Central PMC4390388.
  25. Yen, AM, Auvinen, A, Schleutker, J, Wu, YY, Fann, JC, Tammela, T et al.. Prostate cancer screening using risk stratification based on a multi-state model of genetic variants. Prostate. 2015;75 (8):825-35. doi: 10.1002/pros.22964. PubMed PMID:25683204 .
  26. Kaapu, KJ, Ahti, J, Tammela, TL, Auvinen, A, Murtola, TJ. Sotalol, but not digoxin is associated with decreased prostate cancer risk: A population-based case-control study. Int J Cancer. 2015;137 (5):1187-95. doi: 10.1002/ijc.29470. PubMed PMID:25656312 .
  27. Kilpeläinen, TP, Tammela, TL, Malila, N, Hakama, M, Santti, H, Määttänen, L et al.. The Finnish prostate cancer screening trial: analyses on the screening failures. Int J Cancer. 2015;136 (10):2437-43. doi: 10.1002/ijc.29300. PubMed PMID:25359457 .
  28. Saarimäki, L, Tammela, TL, Määttänen, L, Taari, K, Kujala, PM, Raitanen, J et al.. Family history in the Finnish Prostate Cancer Screening Trial. Int J Cancer. 2015;136 (9):2172-7. doi: 10.1002/ijc.29243. PubMed PMID:25274038 .

Search PubMed